NCT05063305

Probiotics, Immunity, Stress, and QofL

The Efficacy of Probiotics on Immune and Stress Response and Overall Quality of Life

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Loma Linda University · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Accepted

Summary

The purpose of this graduate student research study is to evaluate the efficacy of a multi-strain probiotic and investigate if sex differences influence the role of probiotics on stress and immunity biomarkers.

Detailed description

Visit #1 * Participants will read and sign informed consent forms, HIPPA form, and SAHP Covid-19 screening form. * Participants will perform a baseline oral saliva swab to test for the stress biomarker cortisol and immune markers, including Interleukin-1β (IL-1β) and Tumor Necrosis Factor (TNF). * Swabs will be individually packaged. After opening the package, participants will place the swab under their tongue for 1-2 minutes. * After swabbing is complete, the swab will be placed into the collection tube and capped immediately. * Completed swabs will be placed and held in a sub negative 70° Fahrenheit freezer. * Participants will complete a Quality-of-Life Questionnaire (10-15 minutes). * As this study is double blinded, participants will be separated by gender (male and female) and will select a 90-day supply of placebo or probiotic sample at random. For each gender group there will be 50 samples to select from, comprised of a mix of 25 placebo and 25 probiotic bottles. * Participants will be instructed to take 1 capsule per day for the following 90 days. If a participant misses a day, they should resume taking 1 capsule per day the next day. The capsule should not be crushed or chewed. The capsule may be taken with or without food per participant preference. The participant should consistently take the probiotic at a similar time each day (example: always take it in the morning or evening) Visit #2 * Participants will complete the same Quality-of-Life Questionnaire from visit #1 * Participants will perform a post-study oral saliva swab in the same manner as visit #1

Conditions

• Stress
• Quality of Life

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Probiotic	The probiotic to be used in the study is in capsule form and consists of 12 bacterial strains and 10-billion colony forming unit (CFU). The product consists of the following bacterial strains and species: Bifidobacterium infantis ATCC SD 6720, Bifidobacterium bifidum ATCC SD 6576, Bifidobacterium breve ATCC SD 5206, Bifidobacterium lactis ATCC SD 5220, Bifidobacterium longum ATCC SD 5588, Lactobacillus acidophilus DSM 32754, Lactobacillus casei ATCC SD5213, Lactobacillus paracasei ATCC SD 5275, Lactobacillus plantarum ATCC SD 5209, Lactobacillus reuteri ATCC SD 6689, Lactobacillus rhamnosus ATCC 53103, Lactobacillus salivarius ATCC SD 5208) in combination with the prebiotic, xylooligosacharide (XOS).
DIETARY_SUPPLEMENT	Placebo	A placebo, that will be indistinguishable in appearance to the probiotic, will be provided to half of all study participants for the length of the trial. It will contain the following ingredients: Microcrystalline cellulose, magnesium stearate, a vegetarian capsule, and silicon dioxide. The probiotic will be manufactured by MeriCal.

Timeline

• Start date: 2021-09-27
• Primary completion: 2022-01-27
• Completion: 2022-01-27
• First posted: 2021-10-01
• Last updated: 2022-02-03

Locations

1 site across 1 country: United States